Cancer Medicine Approvals in the US

This cross-sectional study examines trends in cancer medicine approvals by the US Food and Drug Administration (FDA) for adult solid tumors between 2006 and 2025, including both original and supplemental indication approvals.

Authors

Brian Shkabari (ORCID: https://orcid.org/0009-0002-3623-1399)
Nicole I. Vorko
Svasti Sutaria
Bishal Gyawali
Elizaveta Purh
Wesley M. Geerlinks
Claire M. Diana-Gonsalves

Institutions

Queen's University (CA)

Publication Details

Journal: JAMA
Published: 2026-07-30
DOI: https://doi.org/10.1001/jama.2026.12089
Primary Topic: Economic and Financial Impacts of Cancer
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cancer Medicine Approvals in the US

Brian Shkabari, Nicole I. Vorko, Svasti Sutaria, Bishal Gyawali et al.

Jul 30, 2026

JAMA

Economic and Financial Impacts of Cancer

article

Cancer Medicine Approvals in the US

Brian Shkabari, Nicole I. Vorko, Svasti Sutaria, Bishal Gyawali, Elizaveta Purh, Wesley M. Geerlinks, Claire M. Diana-Gonsalves

July 30, 2026article en

Abstract

JAMA

Queen's University (CA)

Zero hunger

Openalex Percentile: Top 4%

Economic and Financial Impacts of Cancer

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.